Company Description
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands.
It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics.
In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; and Veeva RIM that provides regulatory information management capabilities; as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services.
Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration.
The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009.
Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
| Country | United States |
| Founded | 2007 |
| IPO Date | Oct 16, 2013 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 7,291 |
| CEO | Peter Gassner |
Contact Details
Address: 4280 Hacienda Drive Pleasanton, California 94588 United States | |
| Phone | 925 452 6500 |
| Website | veeva.com |
Stock Details
| Ticker Symbol | VEEV |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0001393052 |
| CUSIP Number | 922475108 |
| ISIN Number | US9224751084 |
| Employer ID | 20-8235463 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Peter P. Gassner | Founder, Chief Executive Officer and Director |
| Eleni Nitsa Zuppas | President and Chief of Staff |
| Thomas D. Schwenger | President and Chief Customer Officer |
| Brian Van Wagener | Chief Financial Officer |
| Jonathan W. Faddis J.D. | Senior Vice President, General Counsel and Corporate Secretary |
| Kristine B. Diamond | Principal Accounting Officer |
| Pinal Patel | Chief Information Officer |
| Gunnar Georg Hansen | Director of Investor Relations |
| Jacques Mourrain Ph.D. | Vice President of Quality, Regulatory and Compliance |
| Vivian Welsh | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2025 | 144 | Filing |
| Jul 3, 2025 | 144 | Filing |
| Jun 23, 2025 | 8-K | Current Report |
| Jun 6, 2025 | 144 | Filing |
| Jun 4, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 2, 2025 | 10-Q | Quarterly Report |
| May 28, 2025 | 8-K | Current Report |
| May 13, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 5, 2025 | ARS | Filing |
| May 5, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |